We've sent you an email with a link to update your password.
Customer || Patient Sign in
Reset your password
We will send you an email to reset your password.
We've sent you an email with a link to update your password.
Doctor || Practitioner Sign in
Reset your password
We will send you an email to reset your password.
Product Title: N-Acetyl Selank Amidate X20mg URL handle: n-acetyl-selank-amidate-20mg-biolongevity-labs SKU: NASEL-20MG Brand: Biolongevity Labs Current URL: https://fmihealth.com/products/n-acetyl-selank-amidate-20mg-biolongevity-labs Meta Title: N-Acetyl Selank Amidate X20mg Meta Description: Description--Selank is a synthetic heptapeptide (Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro) derived from the natural regulatory peptide tuftsin. It is primarily studied for its anxiolytic (anti‑anxiety), nootropic (cognitive‑enhancing), immunomodulatory, and antiviral properties. Its activity is linked to modulation of the GABAergic Health Conditions: Anxiety | Cognitive Function | Stress Resilience
Description HTML:
<p>Description--<!--StartFragment -->Selank is a synthetic heptapeptide (Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro) derived from the natural regulatory peptide tuftsin. It is primarily studied for its anxiolytic (anti‑anxiety), nootropic (cognitive‑enhancing), immunomodulatory, and antiviral properties. Its activity is linked to modulation of the GABAergic system and influence on gene expression.</p>
<p> </p>
<p>N‑Acetyl Selank Amidate is a modified version of Selank, engineered through N‑terminal acetylation and C‑terminal amidation. These structural modifications enhance stability, potency, and blood‑brain barrier penetration, extending biological activity compared to standard Selank.</p>
<p> </p>
<p><strong>Mechanistic Claims</strong></p>
<ul>
<li>
<strong>GABAergic Modulation:</strong> Influences GABA receptor activity, contributing to anxiolytic effects.</li>
<li>
<strong>Gene Expression Regulation:</strong> Alters transcriptional activity linked to stress response and cognition.</li>
<li>
<strong>Neuroprotective Effects:</strong> Supports resilience against stress‑induced neuronal changes.</li>
<li>
<strong>Enhanced Stability:</strong> Acetylation and amidation confer resistance to enzymatic degradation.</li>
<li>
<strong>Improved Bioavailability:</strong> Structural modifications increase potency and CNS penetration.</li>
</ul>
<p> </p>
<p><strong>Research Applications</strong></p>
<ul>
<li>Anxiety and stress‑related disorder models</li>
<li>Cognitive enhancement and memory studies</li>
<li>Immunomodulation and antiviral research</li>
<li>Neuroprotection and resilience investigations</li>
<li>Exploratory therapeutic studies in mood regulation and psychiatric conditions</li>
</ul>
<p> </p>
<p><strong>N‑Acetyl Selank Amidate Research Insights</strong></p>
<ul>
<li>Synthetic heptapeptide derived from tuftsin, with anxiolytic and cognitive‑enhancing properties.</li>
<li>Modified through acetylation and amidation for improved pharmacological profile.</li>
<li>Demonstrates enhanced stability and potency compared to standard Selank.</li>
<li>Preclinical studies highlight roles in anxiety reduction, cognitive support, and immune modulation.</li>
<li>Investigated for therapeutic potential in stress‑related disorders, neuroprotection, and antiviral activity.</li>
</ul>
<p><!--EndFragment --><br></p>
<p><strong>N-Acetyl Selank Research</strong></p>
<p>Selank is a multifaceted peptide with significant potential in treating anxiety, cognitive impairments, and stress-related physiological changes. Its ability to modulate the GABAergic system, enhance cognitive function, and exert immunomodulatory effects positions it as a versatile therapeutic agent.</p>
<p class="mt-6 mb-3 base-bold"> </p>
<p class="mt-6 mb-3 base-bold"><em><strong>Anxiolytic and Cognitive Effects</strong></em></p>
<p class="markdown-p">Selank has demonstrated significant anxiolytic properties, comparable to classical benzodiazepines, without the associated side effects such as dependence and memory <span class="whitespace-nowrap">impairment<sup>1</sup>. It has been shown to reduce anxiety in conditions of chronic stress and improve cognitive functions, such as memory and attention, particularly in the context of ethanol-induced impairments. The peptide’s ability to regulate brain-derived neurotrophic factor (BDNF) content in the hippocampus and prefrontal cortex is thought to contribute to its cognitive-enhancing effects<sup>2</sup>.</span></p>
<p class="mt-6 mb-3 base-bold"> </p>
<p class="mt-6 mb-3 base-bold"><em><strong>Immunomodulatory and Antiviral Properties</strong></em></p>
<p class="markdown-p">Beyond its neurological effects, Selank also exhibits immunomodulatory and antiviral properties. It can significantly alter the expression of genes related to chemokines, cytokines, and their receptors, suggesting a role in immune response <span class="whitespace-nowrap">modulation<sup>3</sup>. These properties make Selank a promising candidate for therapeutic applications beyond anxiety and cognitive disorders.</span></p>
<p class="mt-6 mb-3 base-bold"> </p>
<p class="mt-6 mb-3 base-bold"><em><strong>Stress Mitigation and Physiological Effects</strong></em></p>
<p class="markdown-p">Selank has been shown to mitigate stress-induced physiological changes. In animal models, it reduces stress-related morphological changes in organs such as the liver and colon, indicating its potential to alleviate stress-induced <span class="whitespace-nowrap">damage. These effects are likely due to its multifunctional biological activity, which includes reducing corticosterone levels and promoting adaptation to stress<sup>4</sup>.</span></p>
<p> </p>
<p><strong>References</strong></p>
<ol>
<li>
<p>Vyunova, T., Andreeva, L., Shevchenko, K., & Myasoedov, N. (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.. <em>Protein and peptide letters</em>, 25 10, 914-923 . <a href="https://doi.org/10.2174/0929866525666180925144642" rel="noopener" target="_blank">https://doi.org/10.2174/0929866525666180925144642</a>.</p>
</li>
<li>
<p>Kolik, L., Nadorova, A., Antipova, T., Kruglov, S., Kudrin, V., & Durnev, A. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. <em>Bulletin of Experimental Biology and Medicine</em>, 167, 641 – 644. <a href="https://doi.org/10.1007/s10517-019-04588-9" rel="noopener" target="_blank">https://doi.org/10.1007/s10517-019-04588-9</a>.</p>
</li>
<li>
<p>Kolomin, T., Mikhalskaia, P., & Sedelnikova, A. (2023). Changes in Expression of Chemokines, Cytokines and their Receptors under the Action of Selank and its Fragments. <em>Journal of Clinical Physiology and Pathology</em>. <a href="https://doi.org/10.59315/jiscpp.2023-2-2.16-18" rel="noopener" target="_blank">https://doi.org/10.59315/jiscpp.2023-2-2.16-18</a>.</p>
</li>
<li>
<p>Mukhina, A., Mishina, E., Bobyntsev, I., Medvedeva, O., Svishcheva, M., Kalutskiĭ, P., Andreeva, L., & Myasoedov, N. (2020). Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. <em>Bulletin of Experimental Biology and Medicine</em>, 169, 281 – 285. <a href="https://doi.org/10.1007/s10517-020-04868-9" rel="noopener" target="_blank">https://doi.org/10.1007/s10517-020-04868-9</a>.</p>
</li>
</ol>
<p><br>Label--<strong>Peptide Information</strong></p>
<table class="bg-bg-100 min-w-full border-separate border-spacing-0 text-sm leading-[1.88888] whitespace-normal" style="width: 99.9363%;">
<thead class="border-b-border-100/50 border-b-[0.5px] text-left">
<tr class="[tbody>&]:odd:bg-bg-500/10">
<th class="text-text-000 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">Property</th>
<th class="text-text-000 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">Value</th>
</tr>
</thead>
<tbody>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">Peptide Sequence</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2</td>
</tr>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">Molecular Formula</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">C33H57N11O9</td>
</tr>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">Molecular Weight</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">751.9 g/mol</td>
</tr>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">CAS Number</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">129954-34-3</td>
</tr>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">PubChem CID</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">11765600</td>
</tr>
<tr class="[tbody>&]:odd:bg-bg-500/10">
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 27.9556%;">Synonyms</td>
<td class="border-t-border-100/50 [&:not(:first-child)]:-x-[hsla(var(--border-100) / 0.5)] border-t-[0.5px] px-2 [&:not(:first-child)]:border-l-[0.5px]" style="width: 71.5313%;">Selank, 129954-34-3, Selanc, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TP-7</td>
</tr>
</tbody>
</table>
<p> </p>
<p><strong>N-Acetyl Selank Peptide Structure</strong></p>
<p><img data-opt-id="464834253" data-opt-src="https://www.peptidesciences.com/media/wysiwyg/Selank_Structure.png" decoding="async" class="" src="https://www.peptidesciences.com/media/wysiwyg/Selank_Structure.png" alt="Molecule" width="369" height="369" title="N-Acetyl Selank Amidate (20mg) 3" data-opt-lazy-loaded="true" data-opt-optimized-width="369" data-opt-optimized-height="369"></p>
<p>Source<span> </span><a href="https://pubchem.ncbi.nlm.nih.gov/compound/Selank" rel="noopener" target="_blank">PubChem</a></p>
<p> </p>
<p>Dosage--<strong>This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.</strong><span> This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.</span></p>
N-Acetyl Selank Amidate Research Peptide: Stabilized synthetic heptapeptide for preclinical studies on anxiolytic effects, cognitive enhancement, neuroprotection, and immune modulation.
GABAergic & Gene Modulation: Modulates the GABAergic system and influences gene expression, supporting studies on anxiety regulation, stress response, and neurocognitive pathways in laboratory models.
N-Terminal Acetylation: N-acetyl modification improves peptide stability, potency, and blood-brain barrier penetration, enhancing experimental reproducibility and neuropharmacological effects.
Neurocognitive & Immunomodulatory Research Applications: Supports preclinical studies on anxiety, cognitive function, stress resilience, immune regulation, and potential antiviral mechanisms.
Intended Use: For qualified researchers conducting controlled laboratory studies. Not for human or veterinary use.
Quantity selected exceeds current stock
Selank is a synthetic heptapeptide (Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro) derived from the natural regulatory peptide tuftsin. It is primarily studied for its anxiolytic (anti‑anxiety), nootropic (cognitive‑enhancing), immunomodulatory, and antiviral properties. Its activity is linked to modulation of the GABAergic system and influence on gene expression.
N‑Acetyl Selank Amidate is a modified version of Selank, engineered through N‑terminal acetylation and C‑terminal amidation. These structural modifications enhance stability, potency, and blood‑brain barrier penetration, extending biological activity compared to standard Selank.
Mechanistic Claims
GABAergic Modulation: Influences GABA receptor activity, contributing to anxiolytic effects.
Gene Expression Regulation: Alters transcriptional activity linked to stress response and cognition.
Neuroprotective Effects: Supports resilience against stress‑induced neuronal changes.
Enhanced Stability: Acetylation and amidation confer resistance to enzymatic degradation.
Improved Bioavailability: Structural modifications increase potency and CNS penetration.
Research Applications
Anxiety and stress‑related disorder models
Cognitive enhancement and memory studies
Immunomodulation and antiviral research
Neuroprotection and resilience investigations
Exploratory therapeutic studies in mood regulation and psychiatric conditions
N‑Acetyl Selank Amidate Research Insights
Synthetic heptapeptide derived from tuftsin, with anxiolytic and cognitive‑enhancing properties.
Modified through acetylation and amidation for improved pharmacological profile.
Demonstrates enhanced stability and potency compared to standard Selank.
Preclinical studies highlight roles in anxiety reduction, cognitive support, and immune modulation.
Investigated for therapeutic potential in stress‑related disorders, neuroprotection, and antiviral activity.
N-Acetyl Selank Research
Selank is a multifaceted peptide with significant potential in treating anxiety, cognitive impairments, and stress-related physiological changes. Its ability to modulate the GABAergic system, enhance cognitive function, and exert immunomodulatory effects positions it as a versatile therapeutic agent.
Anxiolytic and Cognitive Effects
Selank has demonstrated significant anxiolytic properties, comparable to classical benzodiazepines, without the associated side effects such as dependence and memory impairment1. It has been shown to reduce anxiety in conditions of chronic stress and improve cognitive functions, such as memory and attention, particularly in the context of ethanol-induced impairments. The peptide’s ability to regulate brain-derived neurotrophic factor (BDNF) content in the hippocampus and prefrontal cortex is thought to contribute to its cognitive-enhancing effects2.
Immunomodulatory and Antiviral Properties
Beyond its neurological effects, Selank also exhibits immunomodulatory and antiviral properties. It can significantly alter the expression of genes related to chemokines, cytokines, and their receptors, suggesting a role in immune response modulation3. These properties make Selank a promising candidate for therapeutic applications beyond anxiety and cognitive disorders.
Stress Mitigation and Physiological Effects
Selank has been shown to mitigate stress-induced physiological changes. In animal models, it reduces stress-related morphological changes in organs such as the liver and colon, indicating its potential to alleviate stress-induced damage. These effects are likely due to its multifunctional biological activity, which includes reducing corticosterone levels and promoting adaptation to stress4.
References
Vyunova, T., Andreeva, L., Shevchenko, K., & Myasoedov, N. (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.. Protein and peptide letters, 25 10, 914-923 . https://doi.org/10.2174/0929866525666180925144642.
Kolik, L., Nadorova, A., Antipova, T., Kruglov, S., Kudrin, V., & Durnev, A. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of Experimental Biology and Medicine, 167, 641 – 644. https://doi.org/10.1007/s10517-019-04588-9.
Kolomin, T., Mikhalskaia, P., & Sedelnikova, A. (2023). Changes in Expression of Chemokines, Cytokines and their Receptors under the Action of Selank and its Fragments. Journal of Clinical Physiology and Pathology. https://doi.org/10.59315/jiscpp.2023-2-2.16-18.
Mukhina, A., Mishina, E., Bobyntsev, I., Medvedeva, O., Svishcheva, M., Kalutskiĭ, P., Andreeva, L., & Myasoedov, N. (2020). Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bulletin of Experimental Biology and Medicine, 169, 281 – 285. https://doi.org/10.1007/s10517-020-04868-9.
Dosage--This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.
Selank is a synthetic heptapeptide (Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro) derived from the natural regulatory peptide tuftsin. It is primarily studied for its anxiolytic (anti‑anxiety), nootropic (cognitive‑enhancing), immunomodulatory, and antiviral properties. Its activity is linked to modulation of the GABAergic system and influence on gene expression.
N‑Acetyl Selank Amidate is a modified version of Selank, engineered through N‑terminal acetylation and C‑terminal amidation. These structural modifications enhance stability, potency, and blood‑brain barrier penetration, extending biological activity compared to standard Selank.
Mechanistic Claims
GABAergic Modulation: Influences GABA receptor activity, contributing to anxiolytic effects.
Gene Expression Regulation: Alters transcriptional activity linked to stress response and cognition.
Neuroprotective Effects: Supports resilience against stress‑induced neuronal changes.
Enhanced Stability: Acetylation and amidation confer resistance to enzymatic degradation.
Improved Bioavailability: Structural modifications increase potency and CNS penetration.
Research Applications
Anxiety and stress‑related disorder models
Cognitive enhancement and memory studies
Immunomodulation and antiviral research
Neuroprotection and resilience investigations
Exploratory therapeutic studies in mood regulation and psychiatric conditions
N‑Acetyl Selank Amidate Research Insights
Synthetic heptapeptide derived from tuftsin, with anxiolytic and cognitive‑enhancing properties.
Modified through acetylation and amidation for improved pharmacological profile.
Demonstrates enhanced stability and potency compared to standard Selank.
Preclinical studies highlight roles in anxiety reduction, cognitive support, and immune modulation.
Investigated for therapeutic potential in stress‑related disorders, neuroprotection, and antiviral activity.
N-Acetyl Selank Research
Selank is a multifaceted peptide with significant potential in treating anxiety, cognitive impairments, and stress-related physiological changes. Its ability to modulate the GABAergic system, enhance cognitive function, and exert immunomodulatory effects positions it as a versatile therapeutic agent.
Anxiolytic and Cognitive Effects
Selank has demonstrated significant anxiolytic properties, comparable to classical benzodiazepines, without the associated side effects such as dependence and memory impairment1. It has been shown to reduce anxiety in conditions of chronic stress and improve cognitive functions, such as memory and attention, particularly in the context of ethanol-induced impairments. The peptide’s ability to regulate brain-derived neurotrophic factor (BDNF) content in the hippocampus and prefrontal cortex is thought to contribute to its cognitive-enhancing effects2.
Immunomodulatory and Antiviral Properties
Beyond its neurological effects, Selank also exhibits immunomodulatory and antiviral properties. It can significantly alter the expression of genes related to chemokines, cytokines, and their receptors, suggesting a role in immune response modulation3. These properties make Selank a promising candidate for therapeutic applications beyond anxiety and cognitive disorders.
Stress Mitigation and Physiological Effects
Selank has been shown to mitigate stress-induced physiological changes. In animal models, it reduces stress-related morphological changes in organs such as the liver and colon, indicating its potential to alleviate stress-induced damage. These effects are likely due to its multifunctional biological activity, which includes reducing corticosterone levels and promoting adaptation to stress4.
References
Vyunova, T., Andreeva, L., Shevchenko, K., & Myasoedov, N. (2018). Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.. Protein and peptide letters, 25 10, 914-923 . https://doi.org/10.2174/0929866525666180925144642.
Kolik, L., Nadorova, A., Antipova, T., Kruglov, S., Kudrin, V., & Durnev, A. (2019). Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of Experimental Biology and Medicine, 167, 641 – 644. https://doi.org/10.1007/s10517-019-04588-9.
Kolomin, T., Mikhalskaia, P., & Sedelnikova, A. (2023). Changes in Expression of Chemokines, Cytokines and their Receptors under the Action of Selank and its Fragments. Journal of Clinical Physiology and Pathology. https://doi.org/10.59315/jiscpp.2023-2-2.16-18.
Mukhina, A., Mishina, E., Bobyntsev, I., Medvedeva, O., Svishcheva, M., Kalutskiĭ, P., Andreeva, L., & Myasoedov, N. (2020). Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bulletin of Experimental Biology and Medicine, 169, 281 – 285. https://doi.org/10.1007/s10517-020-04868-9.
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.